磁共振弹性成像可有效无创评估非酒精性脂肪性肝病患者肝纤维化及坏死性炎症活动
该前瞻性研究纳入49例经组织学证实的非酒精性脂肪性肝病患者和41名健康志愿者,评估磁共振弹性成像诊断和分期肝纤维化及区分单纯性脂肪变与非酒精性脂肪性肝炎的性能。磁共振弹性成像区分健康人与非酒精性脂肪性肝病的曲线下面积为0.964,区分进展期纤维化(F3-F4)与无/轻度纤维化(F0-F2)的曲线下面积为0.928,阈值>4.39 kPa时诊断进展期纤维化的敏感度为90.9%、特异度为97.3%。
要点
- 磁共振弹性成像区分健康人与非酒精性脂肪性肝病的曲线下面积为0.964(P<0.0001)。
- 区分进展期纤维化(F3-F4)与无/轻度纤维化(F0-F2)的曲线下面积为0.928(P<0.0001)。
- 阈值>4.39 kPa诊断进展期纤维化的敏感度为90.9%、特异度为97.3%。
核心结论
- 磁共振弹性成像是一种有效的无创方法,可检测和分期非酒精性脂肪性肝病患者的肝纤维化,在区分正常人与非酒精性脂肪性肝病受试者及区分极端纤维化分级方面性能良好;有炎症但无纤维化的非酒精性脂肪性肝病患者肝脏硬度高于单纯性脂肪变患者。
研究设计与样本
- 前瞻性研究,纳入90名受试者(49例非酒精性脂肪性肝病患者和41名健康志愿者),以肝活检确定的纤维化分级和/或炎症分级为参考标准,评估磁共振弹性成像测量的肝脏硬度与组织学分级的相关性、受试者工作特征曲线及诊断性能。
诊断标准与关键数值
- 磁共振弹性成像区分健康人与非酒精性脂肪性肝病患者的曲线下面积为0.964(P<0.0001)。
- 磁共振弹性成像区分进展期纤维化(F3-F4)与无/轻度纤维化(F0-F2)的曲线下面积为0.928(P<0.0001)。
- 阈值>4.39 kPa诊断进展期纤维化的敏感度为90.9%、特异度为97.3%。
- 磁共振弹性成像区分非酒精性脂肪性肝炎与单纯性脂肪变的曲线下面积为0.783(P<0.0001),阈值为3.22 kPa。
临床应用与阅片要点
- 磁共振弹性成像测量的肝脏硬度可用于无创评估非酒精性脂肪性肝病患者的肝纤维化分级。
- 阈值>4.39 kPa有助于诊断进展期纤维化(F3-F4),敏感度为90.9%、特异度为97.3%。
- 有炎症但无纤维化的非酒精性脂肪性肝病患者肝脏硬度高于单纯性脂肪变患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the performance of magnetic resonance elastography (MRE) in diagnosing and staging hepatic fibrosis in patients with histologically confirmed nonalcoholic fatty liver disease (NAFLD) and in distinguishing simple steatosis from nonalcoholic steatohepatitis (NASH).
METHODS: Ninety subjects (49 NAFLD patients and 41 healthy volunteers) were prospectively enrolled. Liver stiffness measured by MRE was correlated with the grade of fibrosis and/or inflammation determined by liver biopsy. Correlations, ROC (receiver operator characteristic) curves and diagnostic performance were evaluated. The study was approved by the local ethics committee.
RESULTS: The area under the ROC curve (AUROC) of MRE in discriminating healthy from NAFLD individuals was 0.964 (P<0.0001), and that for distinguishing advanced (F3-F4) from absent/mild fibrosis (F0-F2) was 0.928 (P<0.0001). The use of a threshold >4.39 kPa resulted in a sensitivity of 90.9% and a specificity of 97.3% for diagnosing advanced fibrosis. For discriminating NASH from simple steatosis, the AUROC was 0.783 (P<0.0001), and the threshold, 3.22 kPa.
CONCLUSIONS: MRE is an effective, non-invasive method for detecting/staging hepatic fibrosis in NAFLD. This method has good performance in discriminating normal from NAFLD subjects and between the extreme grades of fibrosis. NAFLD patients with inflammation and without fibrosis have higher liver stiffness than those with simple steatosis.
引用
- Costa-Silva L, Ferolla SM, Lima AS, et al. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease. Eur J Radiol. 2017. PMID: 29279175. doi:10.1016/j.ejrad.2017.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。